Adaptive Biotechnologies Corporation ADPT
$17.55
▼ -6.03% 24H
About
Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company that develops an immune medicine platform for diagnosing and treating various diseases. The company's core offering is its immunosequencing platform, which uses proprietary chemistry, computational biology, and machine learning to generate…
SectorHealthcare
ExchangeNASDAQ
IndustryDiagnostics & Research
CountryUnited States
Employees624
TickerADPT
Statistics
Market Cap$2.80B
Revenue (TTM)$277.0M
Net Income-$59.5M
Net Margin-21.5%
EPS$-0.39
P/E-47.97
P/S10.15
P/B13.82
EV/EBITDA-91.64
ROE-24.0%
Dividend Yield—
Price$17.55
Data: Twelve Data · Revenue = mcap / P/S